NewGenIVF shares surge 14.03% premarket after announcing $2 million share repurchase program.

NewGenIVF Group surged 14.03% in premarket trading following the announcement of a $2 million share repurchase program on November 10, 2025. The move signals management’s confidence in the stock’s undervaluation, as highlighted by earlier reports suggesting the company’s market value lagged its cash assets. This buyback program directly boosts shareholder value by reducing shares outstanding, enhancing earnings per share, and demonstrating financial discipline. While other recent developments—such as gold-backed asset tokenization, real estate ventures, and reverse merger plans—reflect strategic expansion, the immediate premarket rally aligns with the share repurchase news, which directly impacts equity valuation and investor sentiment.